Please assess the completion status of the following clinical trial:

Trial Title: Early Insertion of Axillary Impella® With VA ECMO

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18~* Impaired LV systolic function with ≤35% of left ventricular ejection fraction (LVEF)~* Enlarged LV with ≥50mm of left ventricular diastolic diameter (LVEDD) on echocardiogram~Exclusion Criteria:~* Non-cardiac etiology~* Surgically correctable cardiac abnormality~* Recent significant pulmonary embolism~* Severe pulmonary hypertension~* Acute aortic dissection~* Presence of mechanical aortic valve prosthesis~* Presence of left ventricle thrombus~* Pre-existing Impella® 5.0~* Critical aortic stenosis~* Uncorrectable system malperfusion under ECMO support~* Significant cerebrovascular accident

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early axillary Impella® (Type: EXPERIMENTAL): Early placement of axillary Impella® for LV unloading and LV recovery in patients with VA ECMO

Based on this trial design, predict the completion outcome and termination type (if applicable).